Cargando…
The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors
Matrix metalloproteinases (MMPs) have been demonstrated to have both detrimental and protective functions in inflammatory diseases. Several MMP inhibitors, with the exception of Periostat(®), have failed in Phase III clinical trials. As an alternative strategy, recent efforts have been focussed on t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823758/ https://www.ncbi.nlm.nih.gov/pubmed/33396445 http://dx.doi.org/10.3390/ph14010031 |